RAS-acting Agents Market Size is Anticipated to Growing at a CAGR of 4.2% by 2031 | TMR Research

Renin-angiotensin system (RAS)-acting agents are a critical component in the management of cardiovascular and renal diseases. These agents, which include angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), and direct renin inhibitors (DRIs), help regulate blood pressure, fluid balance, and electrolyte homeostasis. The RAS-acting agents market plays a vital role in the therapeutic landscape for conditions such as hypertension, heart failure, and chronic kidney disease (CKD).

RAS-acting Agents Market is projected to grow at a CAGR of 4.2% from 2023 to 2031 and reach more than US$ 13.4 Bn by the end of 2031

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85539

Overview of RAS-acting Agents Market
The global RAS-acting agents market is expansive and growing, driven by the increasing prevalence of cardiovascular diseases and hypertension, advancements in drug formulations, and the development of combination therapies. The market includes various drugs such as lisinopril, enalapril, losartan, valsartan, and aliskiren, among others. These agents are available as branded and generic medications, making them accessible to a wide range of patients.

Top Companies:

Novartis AG
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Sanofi S.A.
Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim GmbH
Johnson & Johnson
Other Prominent Players

Recent Developments in RAS-acting Agents Market
Recent advancements and trends in the RAS-acting agents market include:

New Combination Therapies: Development of fixed-dose combination therapies that include RAS-acting agents with other antihypertensive drugs to enhance efficacy and patient compliance.
Extended Release Formulations: Introduction of extended-release formulations to improve dosing convenience and maintain stable drug levels.
Innovative Drug Delivery Systems: Advancements in drug delivery systems to enhance bioavailability and reduce side effects.
Biomarker Research: Ongoing research into biomarkers for better targeting and personalized treatment approaches.

Drivers of Market Growth
Several factors contribute to the growth of the RAS-acting agents market:

Rising Prevalence of Hypertension and Cardiovascular Diseases: Increasing global incidence of hypertension and cardiovascular conditions drives the demand for effective RAS-acting agents.

Aging Population: The growing elderly population, who are more prone to hypertension and related diseases, contributes significantly to market growth.
Advancements in Therapeutics: Continuous innovation in drug formulations and combination therapies enhances treatment options and patient adherence.
Healthcare Awareness and Screening: Greater awareness about the importance of managing blood pressure and regular screening leads to higher diagnosis and treatment rates.

Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85539

Conclusion
The RAS-acting agents market is poised for continued growth, driven by the increasing prevalence of cardiovascular diseases, advancements in therapeutic options, and the rising global demand for effective hypertension management. Innovations in drug formulations, personalized medicine, and emerging market expansion present significant opportunities for market development.

Segmentation

Drug Class
ACE Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Aldosterone Antagonists
Others (diuretics)

Indication
Hypertension
Heart Failure
Chronic Kidney Disease
Diabetic Nephropathy
Coronary Artery Disease

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Region

North America
Europe
Asia Pacific
Middle East & Africa
South America

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=85539<ype=S

More Trending Report by Transparency Market Research:

Gyroscope Market: https://www.globenewswire.com/en/news-release/2024/03/18/2847641/32656/en/Gyroscope-Market-to-be-Worth-USD-1-5-billion-by-2031-Growing-a-CAGR-5-2-Exclusive-Report-by-Transparency-Market-Research-Inc.html

Biopharmaceutical Fermentation Systems Market: https://www.globenewswire.com/news-release/2024/03/01/2838573/32656/en/Biopharmaceutical-Fermentation-Systems-Market-Projected-to-Reach-USD-52-6-billion-by-2031-with-a-CAGR-of-9-5-Report-by-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.